Apartment Investment and Management Co vs Axogen Inc — how do they compare? Apartment Investment and Management Co trades at $2.62 (market cap $376.16M), while Axogen Inc trades at $48.3 (market cap $2.61B). The key difference: Axogen Inc is far larger — about 6.9× Apartment Investment and Management Co's market cap, and Axogen Inc is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| AIV | AXGN | |
|---|---|---|
Market Cap | $376.16M | $2.61B |
Sector | Real Estate | Technology |
52-Week High | $7.93 | $48.48 |
52-Week Low | $2.59 | $14.16 |
Enterprise Value | $738.32M | $2.52B |
Signals from Pluang's Aura AI — not financial advice
AIV trades at $2.62, down 1.5% recently, with a bearish technical signal from moving averages. The company reported Q4 2025 EPS of $1.06, beating expectations, but revenue declined to $138.49M in 2025. Valuation ratios show a low P/B of 0.76, suggesting potential undervaluation, while a net income margin of 400.05% reflects significant one-time tax benefits. Cash flow improved with a net inflow of $234M in 2025.
Outlook is mixed: strong profitability metrics and a scheduled dividend in 2026 offer upside, but inconsistent earnings history and revenue volatility pose risks. Analyst consensus is cautious with 33% buy ratings. Investors should weigh the attractive valuation against operational challenges in the real estate sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →